Marina Sánchez‐Frías

Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease

Mercedes del Río-Moreno, Emilia Alors‐Pérez, Sandra González‐Rubio et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 102 citations · Full text

Medicine, Pathobiology, Pathology +10

Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma

Juan L López-Cánovas, Mercedes del Río-Moreno, Helena García-Fernández et al. · Cancer Letters · 2020 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +14

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing

Juan L López-Cánovas, Natalia Hermán‐Sánchez, Mercedes del Río-Moreno et al. · Experimental & Molecular Medicine · 2023 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing

Juan L López-Cánovas, Natalia Hermán‐Sánchez, María Trinidad Moreno-Montilla et al. · Clinical and Translational Medicine · 2022 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +16